The Congressional Budget Office reported a $1.8 trillion federal deficit for fiscal year 2025, driven in part by a record $1 trillion interest costs from servicing the national debt.

Not every Buffett stock is a winner.

Almost half of those surveyed (48%) would raise menu prices if inflation persisted.

Hello Morning Bid readers! Warnings about a stock market bubble grew louder this week, with the Bank of England, IMF and JPMorgan boss Jamie Dimon all expressing concern about the potential economic fallout if Wall Street were to suddenly stop defying gr

It’s not chaos but it’s not good.

The S&P 500 is on track for a third consecutive year with a double-digit gain.

Werner Enterprises and Bay and Bay Transportation stakeholders shared similarly cautious 12-month outlooks at the FTR Transportation Conference.

Ferrari outlined a revised 2030 sports car line-up comprising 40% internal combustion engine models, 40% hybrids and 20% fully electric vehicles.

FRANKFURT (Reuters) -A digital euro could drain up to 700 billion euros ($810.88 billion) in deposits during a run on commercial banks, pushing around a dozen euro zone lenders into a liquidity squeeze, a European Central Bank simulation showed on Friday.

SHANGHAI (Reuters) -Shares of Chinese battery makers plunged on Friday after the country announced that it would control exports of lithium battery parts, a move that tightens its grip on the technology critical for energy storage and electric vehicles.

The  State Administration for Market Regulation has opened an antitrust investigation into the takeover of connected-vehicle technology provider Autotalks, a deal announced in June. Qualcomm’s shares fell more than 4% in pre-market trading in New York.

MFN-driven drug price reductions are unlikely to impact pharma R&D spending.

The Chinese Ministry of Commerce has now restricted exports of 12 rare earths, adding holmium, erbium, thulium, europium and ytterbium.

NatWest Group’s stock narrative has seen a shift as analysts have slightly raised their consensus price target to £6.05 from £5.99. This reflects growing optimism. Driven by recent research, these upward revisions come amid a backdrop of improved confiden